Table 1.
Participant Characteristics
| Gender | Race | Plasma viral load, RNA copies/mL* [Median] [Range] |
CD4 count, Cells/mm3 [Median] [Range] |
Time Post HIV+ Diagnosis, years [Median] [Range] |
Age, Years [Median] [Range] |
|
|---|---|---|---|---|---|---|
|
| ||||||
| Controllers (n = 4) | M, 2 | AA, 3 | 943 | 769 | 14 | 59 |
| F, 1 | C, 1 | <40 – 1,497 | 431 – 1,128 | 7 – 31 | 50 – 63 | |
| T**, 1 | ||||||
|
| ||||||
| Viremic Untreated (n = 6) | M, 6 | AA, 4 | 57,995 | 324 | 14 | 48 |
| C, 2 | 9,436 – 308,383 | 198 – 516 | 3 – 31 | 33 – 54 | ||
|
| ||||||
| ART-Treated (n = 8) | M, 6 | AA, 4 | <40 | 770 | 9 | 48 |
| F, 2 | C, 4 | NA | 564 – 2,658 | 6 – 30 | 28 – 67 | |
|
| ||||||
| Seronegatives (n = 8) | M, 7 | AA, 5 | NA | 764 | NA | 49 |
| F, 1 | C, 3 | NA | 406 – 2,269 | NA | 26 – 60 | |
M, Male; F, Female; T, Transgender;
**
male-to-female.
AA, African American; C, Caucasian; NA, Not applicable.
*
Median determined using only detectable viral load data points.